Crixmor LLC
↗Malvern, Pennsylvania, USA
Crixmor LLC is a specialized pharmaceutical company and life sciences consultancy based in Malvern, Pennsylvania. Led by veteran pharmaceutical executive Charles H. 'Rusty' Beardsley, the company focuses on the development, licensing, and strategic marketing of therapeutic enzyme preparations and anti-inflammatory agents.
The company is historically associated with 'Ananase,' a brand of bromelain (proteolytic enzymes derived from pineapple) originally developed and marketed by Rhône-Poulenc Rorer. Crixmor LLC positions itself as a niche player in the specialty pharmaceuticals space, leveraging leadership's deep expertise in sales and marketing strategy to explore the re-introduction and commercialization of specialized therapeutic assets within the U.S. and international markets.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1-50
Revenue:< $5M
Founded:2008
Ownership:private
Status:operating
FUNDING
Stage:Seed
PIPELINE
Stage:Discovery
Lead Drug Stage:Preclinical
Modalities:Enzyme therapy, Small molecule
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Historical link to Rhône-Poulenc Rorer (RPR) assets
COMPETITION
Position:Niche Player
Competitors:MediWound Ltd (NexoBrid), Moberg Pharma, Nestlé Health Science
LEADERSHIP
Key Executives:
Charles H. 'Rusty' Beardsley - President & Founder
Scientific Founders:Charles H. Beardsley
LINKS
Website:crixmor.com
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Crixmor LLC and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Crixmor LLC. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.